Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN

Show full item record



Permalink

http://hdl.handle.net/10138/234123

Citation

Diniz , C R A F , Casarotto , P C , Fred , S M , Biojone , C , Castrén , E & Joca , S R L 2018 , ' Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN ' , Neuropharmacology , vol. 135 , pp. 163-171 . https://doi.org/10.1016/j.neuropharm.2018.03.011

Title: Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN
Author: Diniz, Cassiano Ricardo Alves Faria; Casarotto, Plinio C.; Fred, Senem M.; Biojone, Caroline; Castrén, Eero; Joca, Sâmia R.L.
Other contributor: University of Helsinki, Neuroscience Center
University of Helsinki, Neuroscience Center
University of Helsinki, Neuroscience Center
University of Helsinki, Neuroscience Center

Date: 2018-06
Language: eng
Number of pages: 9
Belongs to series: Neuropharmacology
ISSN: 0028-3908
DOI: https://doi.org/10.1016/j.neuropharm.2018.03.011
URI: http://hdl.handle.net/10138/234123
Abstract: The renin-angiotensin system (RAS) is associated with peripheral fluid homeostasis and cardiovascular function, but recent evidence also suggests a functional role in the brain. RAS regulates physiological and behavioral parameters related to the stress response, including depressive symptoms. Apparently, RAS can modulate levels of brain-derived neurotrophic factor (BDNF) and TRKB, which are important in the neurobiology of depression and antidepressant action. However, the interaction between the BDNF/TRKB system and RAS in depression has not been investigated before. Accordingly, in the forced swimming test, we observed an antidepressant-like effect of systemic losartan but not with captopril or enalapril treatment. Moreover, infusion of losartan into the ventral hippocampus (vHC) and prelimbic prefrontal cortex (PL) mimicked the consequences of systemically injected losartan, whereas K252a (a blocker of TRK) infused into these brain areas impaired such effect. PD123319, an antagonist of AT2 receptor (AGTR2), also prevented the systemic losartan effect when infused into PL but not into vHC. Cultured cortical cells of rat embryos revealed that angiotensin II (ANG2), possibly through AGTR2, increased the surface levels of TRKB and its coupling to FYN, a SRC family kinase. Higher Agtr2 levels in cortical cells were reduced after stimulation with glutamate, and only under this condition an interaction between losartan and ANG2 was achieved. TRKB/AGTR2 heterodimers were also observed, in MG87 cells GFP-tagged AGTR2 co-immunoprecipitated with TRKB. Therefore, the antidepressant-like effect of losartan is proposed to occur through a shift of ANG2 towards AGTR2, followed by coupling of TRK/FYN and putative TRIG transactivation. Thus, the blockade of AGTR1 has therapeutic potential as a novel antidepressant therapy. (C) 2018 The Author(s). Published by Elsevier Ltd.
Subject: Angiotensin receptor blocker
Losartan
TRKB
AGTR2
DEPRESSION
TYROSINE KINASE FYN
THERAPEUTIC OPPORTUNITIES
CAPTOPRIL
MESSENGER-RNA
MICE
NEUROTROPHIN RECEPTORS
RAT-BRAIN
STRESS
EXPRESSION
3124 Neurology and psychiatry
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0028390818301187_main.pdf 1.017Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record